Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Emergency use authorization Experimental Vaccine Apr/30/2021 46 0
Astemizole Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/29/2021 2 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 40 46
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Menadione Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/24/2021 2 0
Naphthazarin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/24/2021 1 0
CA521FALA Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Apr/23/2021 13 1
WNbFc 36 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0